Sage Group Advises APR on InLicensing and Acquisition of Novel Pharma Products
ABOUT APR Applied Pharma Research s.a. (www.apr.ch; “APR” or the “Company”) is a profitable, well-financed, privately held, Swiss developer of specialty healthcare products, with over 20 years of experience. APR has a proven track record in successfully developing and marketing novel products in various therapeutic areas on a global basis. APR identifies, in-licenses, develops (using 'state-of-the-art' technology, innovative formulations, dosage forms and delivery systems) an